CN101843660B - Chinese medicament for treating tachycardia - Google Patents

Chinese medicament for treating tachycardia Download PDF

Info

Publication number
CN101843660B
CN101843660B CN2009100937051A CN200910093705A CN101843660B CN 101843660 B CN101843660 B CN 101843660B CN 2009100937051 A CN2009100937051 A CN 2009100937051A CN 200910093705 A CN200910093705 A CN 200910093705A CN 101843660 B CN101843660 B CN 101843660B
Authority
CN
China
Prior art keywords
chinese medicine
radix
chinese medicament
fine powder
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100937051A
Other languages
Chinese (zh)
Other versions
CN101843660A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Jun Zhang Electronics Co., Ltd.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009100937051A priority Critical patent/CN101843660B/en
Publication of CN101843660A publication Critical patent/CN101843660A/en
Application granted granted Critical
Publication of CN101843660B publication Critical patent/CN101843660B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating tachycardia, and belongs to the field of Chinese medicaments for treating cardio-cerebral-vascular system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: costustoot, lucid ganoderma, radix pseudo-ginseng, root of red-rooted salvia and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and nourishing heart and soothing nerves, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

The tachycardic Chinese medicine of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of cardiovascular and cerebrovascular systems.
Background technology
Be intended at present treat the tachycardic field of Chinese medicines, come with some shortcomings: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many tachycardic middle-aged and elderly people are had palpitation for a long time, the torment of cardiopalmus, uncomfortable in chest, tachycardia, had a strong impact on quality of life, patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides the tachycardic Chinese medicine of a kind of treatment, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the tachycardic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
The Radix Aucklandiae 4---20 parts of 30 portions of Ganodermas 2---12 portions of Radix Notoginseng 3---
Radix Salviae Miltiorrhizae 5---40 parts
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Radix Aucklandiae, Radix Salviae Miltiorrhizae perfume (or spice) are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma benefiting QI and nourishing blood in the side, tranquilizing by nourishing the heart has the body resistance strengthening and constitution consolidating, regulates the immunity of organisms effect; Radix Salviae Miltiorrhizae, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; During Radix Aucklandiae circulation of qi promoting is transferred, strengthening the spleen to promote digestion.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of tranquilizing by nourishing the heart, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Radix Aucklandiae 80 kairine sesames 40 gram Radix Notoginseng 60 grams
Radix Salviae Miltiorrhizae 80 grams
Weight in accordance with regulations, with conventional water extraction process the Radix Aucklandiae, Radix Salviae Miltiorrhizae are extracted, make extractum fine powder 48 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 528 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Radix Aucklandiae 160 kairine sesames 60 gram Radix Notoginseng 100 grams
Radix Salviae Miltiorrhizae 200 grams
By above-mentioned same method, make 957 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Radix Aucklandiae 300 kairine sesames 120 gram Radix Notoginseng 200 grams
Radix Salviae Miltiorrhizae 400 grams
By above-mentioned same method, make 1892 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
5 parts of 3 portions of Radix Notoginseng of 6 portions of Ganodermas of the Radix Aucklandiae
8 parts of Radix Salviae Miltiorrhizaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
16 parts of 10 portions of Radix Notoginseng of 20 portions of Ganodermas of the Radix Aucklandiae
30 parts of Radix Salviae Miltiorrhizaes
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science tachycardia, through 7 routine clinical observations.Selecting tcm diagnosis cardiopalmus, tachycardia is standard: pulse is too fast during outbreak, nervous mental confusion, and feeling of distension and oppression over the chest, extremity are numb, and limb is soft weak, heart rate about 160 times/minute.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 4 examples, women's 3 examples do not have other serious disease, and the age is 51 years old-77 years old, 66.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, extremity energetically, cardiac distresses such as nervous cardiopalmus are obviously alleviated or are disappeared, heart district is comfortable, heart rate is below 100 times/minute.
2, effective: body constitution strengthens, and cardiac distresses such as nervous cardiopalmus are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 4 people, effective 2 people, invalid 1 people, total effective rate 85.7%.

Claims (1)

1. the tachycardic Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
The Radix Aucklandiae 4---20 parts of 30 portions of Ganodermas 2---12 portions of Radix Notoginseng 3---
Radix Salviae Miltiorrhizae 5---4 parts
The tachycardic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Radix Aucklandiae, Radix Salviae Miltiorrhizae perfume (or spice) are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009100937051A 2009-09-25 2009-09-25 Chinese medicament for treating tachycardia Expired - Fee Related CN101843660B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100937051A CN101843660B (en) 2009-09-25 2009-09-25 Chinese medicament for treating tachycardia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100937051A CN101843660B (en) 2009-09-25 2009-09-25 Chinese medicament for treating tachycardia

Publications (2)

Publication Number Publication Date
CN101843660A CN101843660A (en) 2010-09-29
CN101843660B true CN101843660B (en) 2011-08-31

Family

ID=42768595

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100937051A Expired - Fee Related CN101843660B (en) 2009-09-25 2009-09-25 Chinese medicament for treating tachycardia

Country Status (1)

Country Link
CN (1) CN101843660B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614271A (en) * 2012-04-20 2012-08-01 北京绿源求证科技发展有限责任公司 Chinese medicine for treating diabetic dyslipidemia
CN102988478B (en) * 2013-01-05 2014-11-05 山东沃华医药科技股份有限公司 Traditional Chinese medicine combination for treating cardiovascular and cerebrovascular diseases and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101554470A (en) * 2008-04-09 2009-10-14 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating tachycardia

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101554470A (en) * 2008-04-09 2009-10-14 北京绿源求证科技发展有限责任公司 Traditional Chinese medicine for treating tachycardia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
王兆辉,王琦,等.常见心脑病证的中医诊断及治疗.《社区医学杂志》.2005,第3卷(第10期),30-36. *
郑梅生.中医药治疗冠心病心律失常的临床研究述评.《中国中医基础医学杂志》.1999,第5卷(第7期),3-7. *

Also Published As

Publication number Publication date
CN101843660A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843661B (en) Chinese medicament for treating angina
CN101843660B (en) Chinese medicament for treating tachycardia
CN101554470A (en) Traditional Chinese medicine for treating tachycardia
CN101843712B (en) Chinese medicament for treating angina
CN101843644B (en) Chinese medicament for treating tachycardia
CN101843753B (en) Chinese medicament for treating angina
CN101843717B (en) Chinese medicament for treating coronary disease
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843755A (en) Chinese medicament for treating diabetic cardiopathy
CN101843645B (en) Chinese medicament for treating tachycardia
CN101843793B (en) Chinese medicament for treating tachycardia
CN101843647B (en) Chinese medicament for treating angina
CN101843720B (en) Chinese medicament for treating angina
CN101849985B (en) Chinese medicament for treating tachycardia
CN101843758B (en) Chinese medicament for treating coronary disease
CN101850034B (en) Chinese medicament for treating angina
CN101843672B (en) Chinese medicament for treating arteriosclerosis
CN101843835B (en) Chinese medicament for treating coronary diseases
CN101843673B (en) Chinese medicament for treating arteriosclerosis
CN101564476B (en) Chinese medicament for treating coronary heart disease
CN101843832B (en) Chinese medicament for treating coronary disease
CN101843729B (en) Chinese medicament for treating cervical spondylosis
CN101843700A (en) Chinese medicament for treating coronary disease
CN101843698A (en) Chinese medicament for treating cervical spondylosis
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO JUNZHANG ELECTRONICS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130809

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130809

Address after: Zhu Yao Cun Bai Pu Zhen 226500 Jiangsu city of Rugao Province in 18 groups

Patentee after: Rugao Jun Zhang Electronics Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110831

Termination date: 20170925

CF01 Termination of patent right due to non-payment of annual fee